Table 3.
Characteristics of all the 11 HPCTs assisted by Genebandhu between May 2012 and June 2018.
| Case | Age (years) | Sex | Disease | CD34 Counts (Million/Kg) recipient body weight | Infusion date | WBC Engraftment (days after infusion) | Chimerism (%) | Current status |
|---|---|---|---|---|---|---|---|---|
| P1 | 12 | Male | AML (relapse) | 4.51 | 03/03/2014 | 12 | 99.60 | Disease free |
| P2 | 72 | Female | AML | 5.5 | 06/02/2015 | 14 | 100 | Disease free |
| P3 | 20 | Male | All | 3.98 | 14/09/2015 | 15 | 100 | Disease free |
| P4 | 9 | Female | Aplastic anemia | 49.7 | 31/08/2016 | NA | NA | Expired; graft failure (day 13) |
| P5 | 4 | Male | Thalassemia major | 7.3 | 12/09/2016 | 18 | 100 | Transfusion free |
| P6 | 59 | Male | Myelofibrosis | 5.3 | 13/03/2017 | 21 | 100 | Expired; Acute GvHD (day 29) |
| P7 | 8 | Male | AML | 14.46 | 17/03/2017 | 33 | 100 | Disease free |
| P8 | 4 | Female | Thalassemia major | 10.16 | 13/04/2017 | 15 | 100 | Transfusion free |
| P9 | 35 | Male | MDS | 10.34 | 07/06/2017 | NA | NA | Expired; graft failure (day 8) |
| P10 | 58 | Female | AML | 5.6 | 19/08/2017 | 15 | NA | Expired; Acute GvHD (day 40) |
| P11 | 30 | Female | AML | 5.37 | 26/10/2017 | 13 | 100 | Alive |
Abbreviations: AML - A cute Myelogenous Leukemia; MDS - Myelodysplastic Syndrome; GvHD- Graft vs. Host disease.